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Introduction. Operative treatment of lumbar spine compression fractures includes fusion and/or cement augmentation. Our aim
was to evaluate postoperative differences in patients treated surgically with fusion, vertebroplasty, or kyphoplasty. Methods. The
Nationwide Inpatient Sample Database search for adult vertebral compression fracture patients treated 2004–2011 identified 102,316
surgical patients: 30.6% underwent spinal fusion, 17.1% underwent kyphoplasty, and 49.9% underwent vertebroplasty. Univariate
analysis of patient and hospital characteristics, by treatment, was performed. Multivariable analysis was used to determine factors
associated with mortality, nonroutine discharge, complications, and patient safety. Results. Average patient age: fusion (46.2),
kyphoplasty (78.5), vertebroplasty (76.7) (𝑝 < .0001). Gender, race, household income, hospital-specific characteristics, and
insurance differences were found (𝑝 ≤ .001). Leading comorbidities were hypertension, osteoporosis, and diabetes. Risks for higher
mortality (OR 2.0: CI: 1.6–2.5), nonroutine discharge (OR 1.6, CI: 1.6–1.7), complications (OR 1.1, CI: 1.0–1.1), and safety related
events (OR 1.1, CI: 1.0–1.1) rose consistently with increasing age, particularly among fusion patients. Preexisting comorbidities and
longer in-hospital length of stay were associated with increased odds of nonroutine discharge, complications, and patient safety.
Conclusions. Fusion patients had higher rates of poorer outcomes compared to vertebroplasty and kyphoplasty cohorts. Mortality,
nonroutine discharge, complications, and adverse events increased consistently with older age.

1. Introduction
Lumbar compression fractures are among the most common medical and surgical conditions encountered by spinal
surgeons [1]. Approximately 1.4 million patients sustain
vertebral compression fractures every year [2], with an annual
inpatient cost just under $5 billion [3]. Compression fractures
disproportionately affect the elderly (65+ years) secondary
to osteoporosis, which is responsible for >700,000 spinal
fracture cases in the United States annually [4]. Although
traumatic lumbar fractures represent a small portion in
all trauma patients, their physical and financial burden on
patients are more significant than other injuries [5].
Standard treatment of vertebral compression fractures
consists of conservative management, including bed rest,

bracing, and analgesics [6]. Studies, however, have noted
that these practices are often insufficient in improving pain
and mobility of these patients [7–9]. Operative interventions,
namely, surgical fusion with instrumentation and cement
augmentation procedures, have been gaining popularity [10,
11] as studies have shown both short-term physical improvements [12–14] and long-term survival benefits [15, 16] in select
patients undergoing surgical intervention for compression
fractures.
Numerous studies have looked at national trends and
outcomes of cement augmentation procedures (vertebroplasty and kyphoplasty) for vertebral compression fractures
[13, 15–18]. These studies, however, do not evaluate differences in demographics and outcomes among surgical fusion,

2.2. Patient Population and Hospital Characteristics. Demographics considered included patients’ age, gender, race,
medical insurance, median income, and preexisting comorbidities. Hospital characteristics such as number of beds,
teaching status, region, and location were documented. Age
was analyzed as a continuous variable using the following
categories: 18–44, 45–64, 65–84, and 85+. In terms of percentages, data was missing for gender (0.07%), race (21.9%),
insurance (0.02%), median income (2.1%), hospital bed size
(2.7%), teaching status (2.7%), and hospital location (2.7%).
2.3. Outcomes of Interest. In-hospital mortality, nonroutine discharge, complications, patient safety indicators, inhospital length of stay (LOS), and total charges were considered in this study. A discharge other than discharge to home
(e.g., transfer, mortality) was considered nonroutine. The
following adverse events were considered in the overall complication rate: neurological, pulmonary, thromboembolic,
cardiac, procedure related, medical, peripheral vascular,
infection, fluid, and electrolyte abnormalities, cerebrospinal
fluid rhinorrhea, stroke, and bleeding.
2.4. Statistical Analysis. Descriptive statistics were used to
summarize patient and hospital characteristics. Bivariate
analysis was used to determine differences in patient/hospital
characteristics and outcomes according to the type of intervention experienced (e.g., cement augmentation and fusion).
Odds ratio (OR), 95% confidence intervals (CI), interquartile
range (IQR), standard deviation (SD), and corresponding
𝑝 values were reported. US nationwide estimates were performed using SAS PROC SURVEY methodology. All analyses
used SAS version 9.1 for Windows (SAS Institute Inc., Cary,
NC). A 𝑝 value ≤ .05 was considered statistically significant.
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2.1. Data Source and Cohort Selection. We utilized the
Nationwide Inpatient Sample (NIS) database to capture
vertebral fracture patients that underwent vertebral cement
augmentation procedures in US hospitals between 2004
and 2011. Using International Classification of DiseasesNinth Revision-Clinical Modification (ICD-9-CM) codes, we
identified adult patients 18 years of age or older with primary
diagnosis of lumbar fracture (ICD-9-CM: 805.4, 806.4);
only patients that underwent a fusion (ICD-9-CM: 81.0–
81.08), kyphoplasty (ICD-9-CM: 81.65), or vertebroplasty
(ICD-9-CM: 81.66) according to the five leading procedures
documented were included. Patients who underwent spine
augmentation for a vertebral fracture secondary to malignancy according to the leading five diagnoses of cancer (ICD9, 1400–1991, 2000–2089) were excluded from this analysis.

Osteoporosis

2. Methods
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kyphoplasty, and vertebroplasty procedures performed for
vertebral compression fractures. This study evaluates patient
demographics and hospital characteristics associated with
each type of treatment as well as assessing potential outcome
differences between patients undergoing fusion, vertebroplasty, and kyphoplasty for vertebral compression fracture.
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Figure 1: Distribution of comorbidities for vertebral compression
fracture patients that underwent a fusion, kyphoplasty, or vertebroplasty between 2000 and 2011 (𝑁 = 102,316). ∗∗∗ 𝑝 < .0001.

3. Results
3.1. Demographics. A total of 102,316 vertebral fracture
patients underwent a cement augmentation or spinal fusion
procedure between 2004 and 2011. A subset of 31,332 (30.6%)
were treated with fusion, 17,456 (17.1%) underwent a kyphoplasty, 51,021 (49.9%) underwent a vertebroplasty, and the
remaining 2,507 (2.5%) had multiple procedures (Table 1).
Patients that underwent a fusion were significantly younger
than the kyphoplasty and vertebroplasty cohorts, 46.2 versus
78.5 and 76.7, respectively (𝑝 < .0001). Only 1.6% of fusion
patients were of age 85+ compared to significant rates found
in kyphoplasty (33.1%) and vertebroplasty cohorts (27.6%).
There were significantly fewer white patients in the fusion
(79.5%) cohort compared to kyphoplasty (87.5%) and vertebroplasty cohorts (88.1%) (𝑝 < .0001). Significantly more
fusion patients had private insurance (46.8%) compared to
kyphoplasty (11.4%) and vertebroplasty cohorts (12.9%) (𝑝 <
.0001). Differences according to median household income
were also documented according to augmentation procedure
type (𝑝 = .0002).
Hospital characteristics according to the type of augmentation procedure were also consistently significant (Table 2).
More fusion patients were treated in large hospitals, teaching
hospitals, and urban hospitals compared to the kyphoplasty,
vertebroplasty, and multiple surgery cohorts (Table 2). A
detailed description of preexisting comorbidities according
to surgical procedure type is illustrated in Figure 1. Overall,
hypertension followed by osteoporosis and diabetes seemed
to be the most common conditions. Fusion patients had
consistently and significantly (𝑝 < .0001) fewer comorbidities compared to kyphoplasty and vertebroplasty cohorts,
independently of the type of comorbidity.
3.2. Univariate Analysis Outcomes. The overall mortality
rate was 0.5%, with a leading rate of 0.8% among patients
that underwent a fusion, 0.7% for kyphoplasty, 0.3% for
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Table 1: Characteristics of 102,316 vertebral compression fracture patients that underwent vertebral augmentation procedures between 2004
and 2011.
All cases
(𝑁 = 102,316)
Age in years
Mean (SE)
Median (IQR)
Age by categories, 𝑁 (%)
18–44
45–64
65–84
85+
Female, 𝑁 (%)
Race, 𝑁 (%)
White
Black
Hispanic
Asian/Pacific Islander
Native American
Other
Primary payer, 𝑁 (%)
Medicare
Medicaid
Private insurance
Self-pay
No charge
Others
Median income, 𝑁 (%)
<$39,000
$39,900–47,999
$48,000–62,999
>$63,000

67.5 (0.4)
73 (54–82)

Vertebral augmentation procedure type
Fusion
Kyphoplasty
Vertebroplasty
𝑁 = 31,332
𝑁 = 17,456
𝑁 = 51,021
(30.6)
(17.1)
(49.9)
46.2 (0.3)
46 (31–58)

78.5 (0.2)
80 (72–86)

76.7 (0.2)
79 (70–85)

Multiple
surgeries
𝑁 = 2,507 (2.5)

𝑝 value§

68.3 (1.0)
72 (57–81)

<.0001
<.0001

15985 (15.6)
19963 (19.5)
45578 (44.5)
20791 (20.3)
60155 (58.8)

14772 (47.1)
11133 (35.5)
4912 (15.7)
516 (1.6)
11597 (37.0)

212 (1.2)
1730 (9.9)
9736 (55.8)
5777 (33.1)
12149 (69.6)

725 (1.4)
6536 (12.8)
29687 (58.2)
14074 (27.6)
34941 (68.5)

276 (11.0)
564 (22.5)
1243 (49.6)
424 (16.9)
1469 (58.6)

71037 (85.4)
2220 (2.7)
5448 (6.6)
1886 (2.7)
347 (0.4)
2195 (2.6)

19560 (79.5)
962 (3.9)
2409 (9.8)
620 (2.5)
162 (0.7)
882 (3.6)

12044 (87.5)
355 (2.6)
757 (5.5)
343 (2.5)
33 (0.2)
233 (1.7)

37651 (88.1)
848 (2.0)
2176 (5.1)
891 (2.1)
147 (0.3)
1030 (2.4)

1782 (87.8)
54 (2.7)
106 (5.2)
32 (1.6)
5 (0.2)
51 (2.5)

<.0001
<.0001∗

<.0001∗
63622 (62.3)
4462 (4.4)
23781 (23.3)
3973 (3.9)
321 (0.3)
5923 (5.8)

5617 (18.0)
3124 (10.0)
14600 (46.8)
3258 (10.4)
237 (0.8)
4354 (14.0)

14642 (84.0)
299 (1.7)
1993 (11.4)
166 (1.0)
10 (0.06)
324 (1.9)

41780 (82.0)
943 (1.9)
6509 (12.9)
473 (0.9)
70 (0.1)
1092 (2.1)

1584 (63.3)
96 (3.8)
590 (23.6)
76 (3.0)
5 (0.2)
153 (6.1)
.0002

24614 (24.6)
27666 (27.6)
25572 (25.5)
22269 (22.20)

8494 (28.0)
8298 (27.3)
7375 (24.3)
6207 (20.4)

3685 (21.4)
4825 (28.1)
4357 (25.3)
4322 (25.1)

11806 (23.6)
13912 (27.8)
13241 (26.4)
11160 (22.3)

629 (25.8)
630 (25.9)
599 (24.5)
580 (23.8)

Rounded percent (%); missing data rates: female (.06), race (18.7), primary payer (.23), and median income (2.1).
§
Comparisons between fusion, kyphoplasty, and vertebroplasty cohorts; ∗ comparisons: white versus others and private versus nonprivate.

vertebroplasty, and 1.4% for multiple procedures cohort (𝑝 <
.0001, Table 3). Approximately half of all patients (55.4%)
were discharged nonroutinely. Kyphoplasty patients were
more likely to be discharged nonroutinely compared to fusion
(51.7%) and vertebroplasty patients (52.7%) and patients that
underwent multiple surgeries (64.3%). The highest rates of
complications were documented among patients that underwent multiple surgeries (25.4%), followed by fusion patients
(24.0%), kyphoplasty patients (21.4%), and vertebroplasty
patients (16.0%). Similarly, fusion patients experienced significantly more adverse safety events (13.5%) when compared
to kyphoplasty (8.8%), vertebroplasty (6.5%), and multiple
procedures patients (12.0%) (𝑝 < .0001).
The average overall in-hospital length of stay was 6.5
days (Table 3). Patients that underwent a fusion spent a
significantly (𝑝 < .0001) longer hospitalization period (9.8

days) compared to the multiple surgeries cohort (7.5 days),
kyphoplasty cohort (5.8 days), and vertebroplasty cohort
(4.6 days). Fusion patients spent an average of $113,067,
while patients that underwent multiple procedures spent an
average of $74,047 (𝑝 < .0001). Kyphoplasty ($34,363) and
vertebroplasty ($42,459) patients had significantly lower total
charges.
3.3. Multivariable Analysis of Patient Outcomes. After adjusting for patient’s age, race, gender, type of insurance, preexisting comorbidities, and length of in-hospital stay, we found
that older age was significantly associated with an increased
risk of mortality (OR 2.0, CI: 1.6–2.5), nonroutine discharge
(OR 1.6, CI: 1.6–1.7), complication (OR 1.1, CI: 1.0–1.1), and
safety adverse events (OR 1.1, CI: 1.0–1.1) (Table 4). Increasing preexisting conditions and longer in-hospital length of
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Table 2: Hospital characteristics of 102,316 vertebral compression fracture patients that underwent vertebral augmentation procedures
between 2004 and 2011.
All cases
(𝑁 = 102,316)
Hospital bed size, 𝑁 (%)
Small
Medium
Large
Teaching hospital, 𝑁 (%)
Yes
No
Hospital region, 𝑁 (%)
Northeast
Midwest
South
West
Hospital location, 𝑁 (%)
Rural
Urban

Vertebral augmentation procedure type
Fusion
Kyphoplasty
Vertebroplasty
𝑁 = 31,332
𝑁 = 17,456
𝑁 = 51,021
(30.6)
(17.1)
(49.9)

Multiple
surgeries
𝑁 = 2,507 (2.5)

𝑝 value§
.001

7442 (7.4)
24182 (23.9)
69525 (68.7)

1341 (4.3)
6928 (22.4)
22617 (73.2)

1539 (8.9)
4011 (23.1)
11792 (68.0)

4410 (8.7)
12580 (24.9)
33482 (66.3)

152 (6.2)
664 (27.1)
1635 (66.7)
<.0001

49599 (49.0)
51550 (51.0)

21819 (70.6)
9066 (29.4)

7944 (45.8)
9397 (54.2)

18595 (36.8)
31877 (63.2)

1241 (50.6)
1210 (49.4)
<.0001

12556 (12.3)
22374 (21.9)
49935 (48.8)
17451 (17.1)

4401 (14.0)
6942 (22.2)
13428 (42.9)
6561 (20.9)

1666 (9.5)
5025 (28.8)
7296 (41.8)
3469 (19.9)

6113 (12.0)
9905 (19.4)
27996 (54.9)
7007 (13.7)

376 (15.0)
501 (20.0)
1216 (48.5)
414 (16.5)

6042 (6.0)
95108 (94.0)

953 (3.1)
29932 (96.9)

1182 (6.8)
16159 (93.2)

3776 (7.5)
46696 (92.5)

130 (5.3)
2321 (94.7)

.0003

Rounded percent (%); missing data rates: female (.06), race (18.7), primary payer (.23), median income (2.1), and hospital data (1.1).
§
Comparisons between fusion, kyphoplasty, and vertebroplasty cohorts.
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Figure 2: Mortality and nonroutine discharge rates by surgical procedure type and age (𝑁 = 102,316).

stays were also significantly associated with higher odds of
mortality, nonroutine discharge, complications, and safety
related events (𝑝 < .0001). Patients that underwent a fusion
procedure had significantly higher odds of mortality (OR
6.2, CI: 3.4–11.3), nonroutine discharge (OR 2.9, CI: 2.5–3.4),
complication (OR 2.2, CI: 1.9–2.6), and safety related event
(OR 1.8, CI: 1.5–2.2) compared to the vertebroplasty cohort.
White patients seemed to have a significant increased risk of
a complication (OR 1.2, CI; 1.0–1.4) and safety related event
(OR 1.2: 1.0–1.5) compared to nonwhite patients.

3.4. Outcome Trends by Age and Surgical Procedure. A consistently increasing trend in mortality as well as nonroutine
discharge was observed among fusion, kyphoplasty, and
vertebroplasty patients with older age (Figure 2). Patients
that underwent a vertebroplasty had consistently higher
mortality independently of age. Similarly, fusion patients
had consistently higher rates of mortality independently
of age. Fusion patients had higher nonroutine discharge
rates compared to all cohorts independently of age. Fusion
patients had significantly higher rates of safety indicators and

BioMed Research International

5

Table 3: Outcomes of 102,316 vertebral compression fracture patients that underwent vertebral augmentation procedures between 2004 and
2011.
Vertebral augmentation procedure type
All cases
Fusion
Kyphoplasty
Vertebroplasty
Multiple
𝑝 value§
(𝑁 = 102,316)
𝑁 = 31,332
𝑁 = 17,456
𝑁 = 51,021
surgeries
(30.6)
(17.1)
(49.9)
𝑁 = 2,507 (2.5)
Mortality rate, 𝑁 (%)
<.0001
560 (0.5)
246 (0.8)
115 (0.7)
164 (0.3)
35 (1.4)
Nonroutine discharge, 𝑁 (%)
<.0001
56650 (55.4)
16184 (51.7)
11971 (68.6)
26883 (52.7)
1611 (64.3)
Length of stay, days
<.0001
Average (SD)
6.5 (0.1)
9.8 (0.1)
5.8 (0.09)
4.6 (0.1)
7.5 (0.3)
Median (IQR)
5 (2–8)
7 (5–11)
4 (3–7)
3 (1–6)
6 (3–10)
Average total charges ($)
<.0001
Average (SD)
72304 (1774)
140484 (3707)
34363 (864)
42459 (796)
99293 (4656)
45361
113067
26581
34898
74047
Median (IQR)
(26251–87838)
(75839–167976)
(17903–41173)
(23504–51781)
(41641–131571)
Complications, 𝑁 (%)
<.0001
Any
20091 (19.6)
7534 (24.0)
3743 (21.4)
8176 (16.0)
637 (25.4)
0
8226 (80.4)
23798 (76.0)
13713 (78.6)
42845 (84.0)
1870 (74.6)
1
17309 (16.9)
5793 (18.5)
3477 (19.9)
7518 (14.7)
522 (20.8)
2
2339 (2.3)
1424 (4.5)
244 (1.4)
593 (1.2)
78 (3.1)
3+
442 (0.4)
316 (1.0)
23 (0.1)
65 (0.1)
38 (1.5)
Patient safety indicators, 𝑁 (%)∗
Any
<.0001
9406 (9.2)
4235 (13.5)
1537 (8.8)
3334 (6.5)
300 (12.0)
0
92910 (90.8)
27097 (86.5)
15919 (91.2)
47687 (93.5)
2207 (88.0)
1
8107 (7.9)
3444 (11.0)
1365 (7.8)
3047 (6.0)
251 (10.0)
2
1015 (1.0)
627 (21.0)
118 (0.7)
231 (0.5)
40 (1.6)
3+
286 (0.3)
164 (0.5)
55 (0.3)
57 (0.1)
9 (0.4)
Rounded percent (%).
§
Comparisons between fusion, kyphoplasty, and vertebroplasty cohorts.
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Figure 3: Complication and patient safety rates by surgical procedure type and age (𝑁 = 102,316).

complications compared to all other cohorts, independently
of age (Figure 3).

4. Discussion
Lumbar compression fractures represent a leading cause of
morbidity and mortality in the United States. Understanding

the role of different surgical treatments in survival, complications, and other outcomes of interest is imperative in order
to determine optimum treatment modalities. With increasing
evidence supporting surgical intervention for these patients
[12, 15, 16, 19–23], numerous studies have sought to compare
outcomes among different treatment paradigms [6, 12, 15,
17, 24, 25]. Surgical fusion with instrumentation and cement

1.0 (0.9–1.1)
1.3 (1.3-1.3)
2.9 (2.5–3.4)
1.5 (1.3–1.7)
1.2 (1.2-1.2)

.51
.54
<.0001
.04
<.0001

1.3 (0.6–1.6)
0.8 (0.4–1.6)
1.1 (0.9–1.2)
6.2 (3.4–11.3)
1.7 (1.0–3.0)
1.1 (1.1-1.1)

1.1 (1.0–1.3)

<.0001
<.0001
<.0001

.79
<.0001

.08

2.2 (1.9–2.6)
1.2 (1.1–1.4)
1.1 (1.1-1.1)

1.0 (0.9–1.1)
1.6 (1.6–1.7)

1.2 (1.0–1.4)

1.0 (0.9–1.1)

<.0001

1.2 (1.1–1.3)

.14

0.7 (0.4–1.1)

Complication
OR (95% CI)
1.1 (1.0–1.1)

<.0001

2.0 (1.6–2.5)

Outcome analysis excludes patients that had multiple procedures (𝑁 = 1,856, 2.5%).
∗
Unit increments.

Age in decades
Gender (ref: male)
Female
Race (ref: nonwhite)
White
Insurance (ref: nonprivate)
Private
Comorbidities∗
Type of procedure (ref: vertebroplasty)
Fusion
Kyphoplasty
Length of stay, days

𝑝 value

Mortality, OR
(95% CI)

Outcomes
Nonroutine
𝑝 value
discharge OR
(95% CI)
1.6 (1.6–1.7)
<.0001

<.0001
.003
<.0001

.91
<.0001

.02

.40

.002

𝑝 value

1.8 (1.5–2.2)
1.1 (0.9–1.3)
1.1 (1.1-1.1)

1.1 (0.9–1.3)
1.3 (1.2–1.4)

1.2 (1.0–1.5)

0.7 (0.6–0.8)

Patient safety
indicators OR
(95% CI)
1.1 (1.0–1.1)

<.0001
.19
<.0001

.26
<.0001

.03

<.0001

<.0001

𝑝 value

Table 4: Adjusted odds ratio (OR) and 95% confidence intervals (CI) for factors associated with mortality, nonroutine discharge, complication, and safety related adverse events (𝑁 = 102,316).
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augmentation have been of primary interest, as both procedures have seen increased utilization from the early 1990s
to 2000s (12.9% for cement augmentation patients and 39%
for surgical fusion) [26, 27]. Although numerous studies
have compared outcomes between nonsurgical intervention,
vertebroplasty, and kyphoplasty [12, 13, 15, 17, 18, 27], there
have been no published studies comparing outcomes between
vertebroplasty, kyphoplasty, and surgical fusion. The goal
of our study was to evaluate differences in demographics
and hospital characteristics as well as compare postsurgical
outcomes between vertebroplasty, kyphoplasty, and fusion
patients with the primary diagnosis of vertebral compression
fractures.
Our findings suggest a slight female preponderance
(58.8%) of patients undergoing surgery for lumbar spine
trauma, with significantly more females receiving kyphoplasty (69.6%) and vertebroplasty (68.5%) compared to spinal
fusion (37.0%). In the United States, the risk of developing
a fragility fracture is up to 40% for women and 13% for
men over the age of 50 [28]. More specifically, vertebral
compression fractures occur in approximately 16% of all
postmenopausal women [29]. In our cohort, 64.8% of lumbar
trauma patients undergoing surgical intervention were over
the age of 65. Significantly younger patients underwent
surgical fusion (46.2 years) versus kyphoplasty (78.5 years)
and vertebroplasty (76.7 years) procedures. This is consistent
with an institutional study by Hsieh et al., which reported
significantly older patients in their kyphoplasty versus shortsegment fixation with I-VEP cohort [30]. Lad et al. reported
that, within their cohort of vertebral spinal fracture patients,
a majority were women and over the age of 65 [27]. As
age and gender may be connected in this population, the
explanation of higher percentages of elderly patients and
women undergoing augmentation procedures may be related.
The most common mechanisms for the occurrence of
lumbar spine trauma include falls, sport accidents, and motor
vehicle crashes [31]. However, in elderly patients, osteoporosis
is responsible for >700,000 vertebral compression fractures
in the United States annually [4]. We found that osteoporosis
was the second leading comorbidity for all lumbar spine
trauma patients, with significantly higher percentages in
cement augmentation versus surgical fusion cohorts. The
leading comorbidity was hypertension, which is known to
have high prevalence in elderly populations [32]. In 1990,
the United States Census Bureau estimated that over 16
million Americans will be 85 years or older by the year
2050 [33]. Thus, the effect of age on outcomes and treatment
for vertebral compression fracture patients is an important
health-care problem of increasing impact. We found that,
regardless of procedure, an increase in age is associated with
higher nonroutine discharge rates, complication rates, and
patient safety rates. Mortality rates for cement augmentation procedures remained relatively stable with increased
age, while rates for fusion patients increased dramatically,
especially in patients >65 years old.
Fusion patients as a whole had consistently higher mortality, complication, nonroutine discharge, and patient safety
rates compared to their augmentation counterparts. There
were also significantly more fusion procedures performed at
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large, urban teaching hospitals. Daniels et al. reported similar
findings while evaluating hospital-based rates of thoracolumbar spine arthrodesis for patients with spinal fractures. They
reported that hospitals with higher volumes of spinal fracture
patients had higher fusion rates compared to hospitals treating fewer fracture patients [31]. This may indicate that fusion
procedures are more complex in nature, which would explain
the younger patients, lower comorbidities of patients, and
increased adverse outcomes. Patients who underwent fusion
were 6.2 times more likely to experience morality, 2.9 times
more likely to have a nonroutine discharge, 2.2 times more
likely to have a complication, and 1.8 times more likely to
have PSI as compared to vertebroplasty patients. Similarly,
kyphoplasty patients had higher percentages of adverse outcomes, such as a 70% increase in mortality, when compared
to vertebroplasty patients. Chen et al. had contrary findings,
which suggested that an adjusted risk of death was 20% lower
for kyphoplasty patients versus vertebroplasty patients [15].
In a meta-analysis of literature, Eck et al. evaluated pain
relief and risk of complications associated with kyphoplasty
and vertebroplasty [25]. Their findings suggest that although
both methods of augmentation are effective in relieving pain,
there is a significant increase in pain relief for vertebroplasty
patients versus kyphoplasty patients [12]. However, it was
also reported that vertebroplasty patients had higher rates of
complications compared to their kyphoplasty counterparts,
including increased cement leakage and higher occurrence
of sustaining subsequent vertebral fractures [34, 35]. These
inconsistencies in results comparing vertebroplasty and
kyphoplasty procedures and lack of studies comparing augmentation procedures to spinal fusion procedures call for further research. Prospective studies with appropriate matching
of individuals undergoing each treatment type would address
limitations of current studies and lead to more concrete
results regarding the clinical outcomes of patients undergoing
surgical intervention for lumbar spine trauma [15].
4.1. Limitations. Although utilization of national databases
may be advantageous, namely, due to high volume of patients
and avoidance of selection bias, there remain considerable
limitations. Such limitations include potential coding errors,
lack of data specifying type of injury and severity, and
absence of long-term outcomes or disability scores [1, 26, 27].
Additionally, the codes and the coding used by physician may
not be specific for compression fractures. Populations with
operative fractures versus those with fractures treated with
kyphoplasty/vertebroplasty are likely completely different
with regard to injury severity, neurologic status, and so forth.
Our goal in this study was to present the general trend in
compression fractures in the elderly population over the years
studied. Therefore, our findings should be considered with
these points in mind.

5. Conclusions
Treatment patterns of patients with vertebral compression
fractures differ significantly when comparing patient demographics and hospital type and location. Age and medical
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comorbidities are significant risk factors for mortality and
adverse outcomes regardless of procedures. Spinal fusion was
associated with higher risk of adverse outcomes compared
to cement augmentation. Kyphoplasty was associated with
higher risk of adverse outcome compared to vertebroplasty.
Elderly patients and those with medical comorbidities appear
to strongly have the potential for poorer outcomes regardless
of what type of procedure is performed.
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